University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 2N-12-7


DNA Methylation Markers for Detecting Cancer Cells in Malignant Pleural Effusion.

Type: Diagnostic
Phase: Not Applicable
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Daniel Oh, M.D.
Other Trial Staff:  Stephanie Worrell, Coordinator

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1All patients from the clinic or inpatient ward of USC University Hospital, Norris Cancer Center, and Los Angeles County Hospital presenting with pleural effusion.


You may not participate in this study if:
1<18 years old
2Pregnant females
3Unable to consent for thoracentesis
4<400 ml of pleural fluid on thoracentesis



For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.